Læknaneminn - 01.10.1991, Side 64

Chiquet-Ehrismann, R., Mackie, E.J., Pearson, C.A. &
Sakakura, T. (1986). Tenascin: an extracellular matrix
protein involved in tissue interactions during fetal
development and oncogenesis. Cell, 47, 131-139.
Dickson,R.B. & Lippman,M.E.(1987)Estrogenicregulat-
ion of growth and polypeptide growth factor secretion in
human breast carcinoma. Endocrine Rev., 8, 29-43.
Druker, B.J., Mamon, H.J. & Roberts, T.M. (1989)
Oncogenes, Growth factors, and signal transduction. New
Engl. J.Med.,321,1383-1391.
Erickson, C.A. (1990) Cell migration in the embryo and
adult organism. Current Opinion in Cell Biol., 2, 67-74.
Ferguson, J.E., Schor, A.M., Howell, A. & Ferguson,
M.W.J. (1990) Tenascin distribution in the normal human
breast is altered during the menstrual cycle and in
carcinoma. Differentiation, 42, 199-207.
Fuchs, E. (1990) Epidermal differentiation. Current
Opinion in Cell Biol., 2, 1028-1035.
Gullick, W.J. (1990) Growth factors and oncogenes in
breast cancer. Progr. in Growth Factor Res., 2, 1-13.
Heyworth,CM.,Vallance,S.J.,Whetton, A.D.&DexterT.M.
(1990). The biochemistry & biology of the myeloid haemo-
poietic cell growth factors. J. Cell Sci. Suppl. 13, 57-74.
Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C.C.
(91) p53 mutations in human cancers. Science, 253,49-53.
Knudson, A.S. (1985) Hereditary cancer, oncogenes and
anti-oncogenes. CancerRes.,45, 1437-1443.
Lambert, S. Collette, J., Gillis, J., Franchimont, P., Desaive,
C. & Gol-Winkler, R. (1991) Turnor IGF-II content in a
patient with a colon adenocarcinoma correlates with
abnormalexpressionofthegene. IntJ. Cancer, 48,825-830.
Mackay, A.R., Hartzler, J.L.,Pelina,M.D. & Thorgeirsson,
U.P. (1990) Studies on the ability of 65-kDa and 92-kDa
tumor cell gelatinases to degrade type IV collagen. J. Biol.
Chem., 265,21929-21934.
Sachs, L. (1990) The ntolecular control of normal and
leukemic hematopoiesis: Myeloid cells as a model system.
Ann N.Y. Acad. Sciences, 567, 141-153.
Schor, S.L. & Schor, A.M. (1987) Foetal-to-adult
transitions in fibroblast phenotype: theirpossible relevance
tothepathogenesisofcancer. J.Cell Sci.,Suppl. 8,165-180.
Sporn, M.B., Roberts, A.B., Wakefield, L.M. & Assoian,
R.K. (1986) Transforming growth factor-6: biological
function and chemical structure. Science, 233, 532-534.
Sporn, M.B. & Roberts, A.B. (1990) Regulation of cell diff-
erentiation and proliferation by retinoids and transforming
growth factor B.: Burger, M.M., Sordat, B. & Zinkernagel,
R.M. (Rstj.): Cell to Cell Interaction. Karger, Basel. B. 2-15.
Stein,G.S., Lian,J.B.&Owen,T.A.Bonecelldiffertiation:
a functionally coupled relationship between expression of
cell-growth-and tissue-specific genes. Current Opinion in
CellBiol.,2, 1018-1027.
Thorlacius, S., Jónasdóttir, O. & Eyfjörð, J. (1990) Loss of
heterozygosity and oncogene amplification in primary
human breast tumors. EMBL Conference on Oncogenes and
Growth Control. Abstr. 50.
Tryggvason, K., Höyhtya, M. & Salo, T. (1987) Proteolytic
degradation of extracellular matrix in tumor invasion.
Biochim. Biophys. Acta, 907, 191-217.
Tulinius, H., Day, N.E., Bjarnason, O., Geirsson, G.,
Jóhannesson, G., Gonzalez, M.A.L. de, Sigvaldason, H.,
Bjarnadóttir, G & Grímsdóttir, K. (1982) Familial breast
cancer in Iceland. Int.J.Cancer, 29, 365-371.
Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs.,
Kimchi, A., Oren, M. Wild type p53 induces apoptosis of
myeloid leukaemic cells that is inhibited by interleukin-6,
Nature, 352, 345-347.
Varley, J.M., Swallow, J.E., Brammar, W.J., Whittaker, J.L.
& Walker, R. A. (1987) A1 terations to either c- erbB-2 (neu)
or c-myc proto-oncogenes in breast carcinomas correlate
with poor short-term prognosis. Oncogene, 1,423-430.
Warn, R.M. & Dowrick, P. (1989) Motility factors on the
march. Nature, 340, 186-187.
Waterfield, M.D. (1987) The role of growth factors in
cancer. í: Franks,L.M. & Teich, N.(Ritstj.): Introduction to
the Cellular and Molecular Biology of Cancer. Oxford
University Press, Oxford. 251-276.
Williams, T.W., Smith, C.A., Spooncer, E., Dexter, T.M. &
Taylor, D.R. (1990) Haemopoietic colony stimulating
factors promote cell survival by suppressing apoptosis.
Nature, 343, 76-78.
62
LÆKNANEMINN 2 1991 44. árg.